JPMorgan analyst, Anupam Rama, reiterated an Overweight rating and $27.00 price target on Dynavax Technologies (NASDAQ: DVAX) ahead of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE